Envista Holdings Corp
NVST21.945USD
-0.055-0.25%
Market hours （ET）Quotes delayed by 15 min
3.62BMarket Cap
233.26P/E TTM
More Details of Envista Holdings Corp Company
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Envista Holdings Corp Info
Ticker SymbolNVST
Company nameEnvista Holdings Corp
IPO dateSep 18, 2019
CEOKeel (Paul A)
Number of employees12300
Security typeOrdinary Share
Fiscal year-endSep 18
Address200 S. Kraemer Blvd., Bldg. E
CityBREA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code92821
Phone17148175418
Websitehttps://envistaco.com/en
Ticker SymbolNVST
IPO dateSep 18, 2019
CEOKeel (Paul A)
Company Executives of Envista Holdings Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-1.44%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-9.73%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-4.05%
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
33.32K
-61.88%
Mr. J. Andrew Pierce
Mr. J. Andrew Pierce
Independent Director
Independent Director
--
--
Mr. Eric D. Hammes
Mr. Eric D. Hammes
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-1.44%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-9.73%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Northern America
347.90M
51.00%
Western Europe
154.10M
22.59%
Other developed markets
150.40M
22.05%
Emerging markets
29.70M
4.35%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.93%
BlackRock Institutional Trust Company, N.A.
8.71%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.80%
Franklin Mutual Advisers, LLC
5.29%
Other
62.98%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.93%
BlackRock Institutional Trust Company, N.A.
8.71%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.80%
Franklin Mutual Advisers, LLC
5.29%
Other
62.98%
Shareholder Types
Shareholders
Proportion
Investment Advisor
53.21%
Investment Advisor/Hedge Fund
47.49%
Hedge Fund
10.48%
Research Firm
1.56%
Pension Fund
1.39%
Sovereign Wealth Fund
1.38%
Individual Investor
0.52%
Bank and Trust
0.50%
Private Equity
0.36%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
2023Q2
772
187.89M
114.71%
-18.52M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
16.92M
10.18%
-100.35K
-0.59%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.69M
8.84%
-735.51K
-4.77%
Jun 30, 2025
Ariel Investments, LLC
12.36M
7.43%
+210.92K
+1.74%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
9.17M
5.52%
+783.21K
+9.34%
Jun 30, 2025
Franklin Mutual Advisers, LLC
8.95M
5.39%
+1.28M
+16.75%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
10.81M
6.51%
-1.33M
-10.92%
Jun 30, 2025
Harris Associates L.P.
7.81M
4.7%
-869.00K
-10.01%
Jun 30, 2025
Gates Capital Management, Inc.
6.33M
3.81%
+1.16M
+22.55%
Jun 30, 2025
AllianceBernstein L.P.
6.10M
3.67%
+1.55M
+34.01%
Jun 30, 2025
Victory Capital Management Inc.
5.75M
3.46%
+313.66K
+5.77%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.75%
Schwab Ariel Opportunities ETF
Proportion1.51%
Pacer US Export Leaders ETF
Proportion0.88%
Distillate Small/Mid Cash Flow ETF
Proportion0.58%
Royce Quant Small-Cap Quality Value ETF
Proportion0.5%
Harbor Long-Short Equity ETF
Proportion0.45%
First Trust Health Care Alphadex Fund
Proportion0.41%
iShares U.S. Medical Devices ETF
Proportion0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.3%
DFA Dimensional US Small Cap Value ETF
Proportion0.27%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Envista Holdings Corp?
The top five shareholders of Envista Holdings Corp are:
The Vanguard Group, Inc. holds 16.92M shares, accounting for 10.18% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 14.69M shares, accounting for 8.84% of the total shares.
Ariel Investments, LLC holds 12.36M shares, accounting for 7.43% of the total shares.
Dimensional Fund Advisors, L.P. holds 9.17M shares, accounting for 5.52% of the total shares.
Franklin Mutual Advisers, LLC holds 8.95M shares, accounting for 5.39% of the total shares.
The Vanguard Group, Inc. holds 16.92M shares, accounting for 10.18% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 14.69M shares, accounting for 8.84% of the total shares.
Ariel Investments, LLC holds 12.36M shares, accounting for 7.43% of the total shares.
Dimensional Fund Advisors, L.P. holds 9.17M shares, accounting for 5.52% of the total shares.
Franklin Mutual Advisers, LLC holds 8.95M shares, accounting for 5.39% of the total shares.
What are the top three shareholder types of Envista Holdings Corp?
The top three shareholder types of Envista Holdings Corp are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Ariel Investments, LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Ariel Investments, LLC
How many institutions hold shares of Envista Holdings Corp (NVST)?
As of 2025Q3, 713 institutions hold shares of Envista Holdings Corp, with a combined market value of approximately 196.49M, accounting for 119.50% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -0.62%.
What is the biggest source of revenue for Envista Holdings Corp?
In FY2025Q2, the -- business generated the highest revenue for Envista Holdings Corp, amounting to -- and accounting for --% of total revenue.
